OCUGEN, INC.
OCGNCIK 0001372299
Revenue (TTM)
$6.14M
+8.8% YoY
Q1 Apr 2026
Net Income (TTM)
−$69.32M
−25.5% YoY
Q1 Apr 2026
EPS Diluted (TTM)
−$0.20
−420.0% YoY
Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-1,038.6%
Q1 Apr 2026
Net Margin
-1,129.1%
Q1 Apr 2026
Free Cash Flow (TTM)
−$73.97M
Q1 Apr 2026
Cash
$31.9M
Q1 Apr 2026
Total Debt
$24.19M
Q1 Apr 2026
Shares Outstanding
338.52M sh
Q1 Apr 2026